news

On November 8, 2025, the “Health Industry Development and Brand Safety Protection Forum and Food and Drug E-commerce Live Streaming Operation Exchange Seminar,” hosted by the Beijing Health Industry Association, was held at the People’s Public Security University of China. Ms. Wu Xia, Chairman of Taiai Peptide Group, was invited to attend this industry event and was elected as Vice President of the Beijing Health Industry Association at the Association’s Second Third Member Congress, demonstrating the Group’s professional influence and industry status in the health field.

  This forum focused on the high-quality development of the health industry and brand safety protection, bringing together numerous authoritative experts from government departments, academia, and the business community. During the morning session, experts including the Director of the Food, Drug, and Environmental Crime Research Center of the People’s Public Security University of China and a member of the State Council Food Safety Commission’s Special Committee delivered keynote speeches, conducting in-depth discussions on hot topics such as food and drug safety supervision, compliant e-commerce live streaming operations, and brand intellectual property protection, providing valuable policy interpretations and practical guidance for participating companies.

At the Second Session of the Third Member Congress and Council Meeting of the Beijing Health Industry Association held in the afternoon, Ms. Wu Xia, Chairwoman of Taiai Peptide Group, was officially elected as Vice President of the Association. During the subsequent awarding ceremony, the Chairwoman received the certificate of honor from the Association leaders and delivered a speech as a representative of the newly elected Vice Presidents.

In her speech, Chairwoman Wu Xia expressed her honor at being elected as the Vice President of the Association, stating that it was both an honor and a responsibility. She introduced the history of Tai’ai Peptide Group’s years of dedication to the field of bioactive peptides and its commitment to the development of the health industry. She emphasized that in the future, she will actively fulfill her responsibilities as Vice President, fully utilize the association’s platform, and work hand in hand with colleagues from all walks of life to jointly promote technological innovation, standard setting, and industry self-regulation in the health industry, contributing the power of “Tai’ai Peptide” to safeguarding national health and ensuring brand safety.

This election is not only a high recognition of Taiai Peptide Group’s corporate strength and brand reputation by the industry, but also provides a new opportunity for the group to participate in industry co-construction and lead the healthy development of the industry on a broader platform.